Recruiting

SVRd for the Treatment of Newly Diagnosed Multiple Myeloma Patients Presenting With Extramedullary Disease

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(6 sites)

China

Changzhou Second People's Hospital, Changzhou, Jiangsu

Nanjing First People's Hospital, Nanjing, Jiangsu

The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu

Affiliated Hospital of Nantong University, Nantong, Jiangsu

Taizhou People's Hospital, Taizhou, Jiangsu

Yancheng First People's Hospital, Yancheng, Jiangsu